Integrating Methylene Dichloride into Continuous Pharma Manufacturing: What Works and What Doesn’t
Continuous pharmaceutical manufacturing is gaining momentum as the industry seeks greater efficiency, consistency, and scalability. Within this evolving landscape, methylene dichloride (MDC) continues to play a specialised role due to its solvency power and process efficiency. However, its integration into continuous systems requires careful evaluation. One of MDC’s primary advantages lies in its volatility and strong solvating ability, which support rapid reaction kinetics and efficient separations. In continuous processes, these properties can translate into shorter residence times and improved throughput. For certain synthesis and purification steps, MDC remains difficult to replace without compromising process performance. That said, continuous manufacturing intensifies the need for robust containment and control strategies. MDC’s toxicity profile demands closed systems, effective vapour recovery, and real-time monitoring to protect both operators and the environment. Unlike batch ...